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Abstract
Background: Dipteryx alata Vogel popularly known as “baru” is an important commercial leguminous tree species
from the Brazilian Cerrado, which possess medicinal properties, besides its fruits consumption by animals and
humans. The use of the “naturally occurring plants” as herbal remedies and foods mainly from leaves, seeds,
flowers and roots of plants or extracts require precautions before ensuring these are safe and efficacious. The
objective of this study was to evaluate the safety of D. alata barks extract.
Methods: Vegetal drugs of D. alata barks were submitted to quality control assays and further to the safety assays
under 1) in vitro parameter by Salmonella (Ames) mutagenicity, and 2) in vivo parameter on the pregnancy of rats.
Results: The extract was non-mutagenic to any of the assessed strains TA97a, TA98, TA100 and TA102 even after
metabolic activation (+S9). All in vivo parameters (reproductive ability evaluation, physical development of rat
offsprings, and neurobehavioral development assays) showed no changes related to control group.
Conclusion: D. alata barks extract is neither mutagenic by the Ames test nor toxic in the pregnancy of rats, with
no physical-neurobehavioral consequences on the rat offsprings development.
Background
Dipteryx alata Vogel belongs to Leguminosae family,
popularly known as “baru” [1]. Its fruits are consumed
by cattle and wild animals [2] and as sweetmeat by
humans [3]. Its seeds are edible, nutritive and the oil
has medicinal properties [1,2,4], whereas other parts
from plant are popularly used as anti rheumatic, tonic
and menstrual regulator [5].
One in five individuals taking prescriptions also use
herbal remedies or nutritional supplements [6], despite
the risks for adverse drug reactions resulting from inter-
actions between herbal remedies and prescription phar-
maceuticals. In addition, there are some herbs that are
known as teratogens that should under no circum-
stances be taken during pregnancy, such as Semen croto-
nis, Semen pharbitidis, Radix euphorbiae, Radix
phytolaccae, Rhizoma sparganii, and Rhizoma zedoariae;
whereas other herbs are recognized as potentially dan-
gerous for fetuses, such as Semen persicae and Radix
aconiti [7]. Recently, a new pharmacological anti snake
venom was attributed to D. alata [8].
All these properties make D. alata very attractive for
food consumption and medicinal use, although there is
no information concerning its safety. In previous studies
[9] the IC50 was determined and the obtained value was
used to calculate the LD50. Here, we used in vitro
(Ames test) and in vivo (developmental and reproductive
toxicology) assays to evaluate the mutagenic properties
of D. alata barks extract and its effects on reproduction.
Methods
Plant material and extraction
The barks of an adult Dipteryx alata Vogel tree were
collected in Pedro Afonso (Tocantins, Brazil) in Decem-
ber 2007. D. alata specimens were identified by Dr.
Roseli B. Torres from “Núcleo de Pesquisa e Desenvolvi-
mento do Jardim Botânico”, Institute of Agronomy of
Campinas. The voucher specimen was deposited (IAC
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50629) at the herbarium of the Institute of Agronomy of
Campinas (Brazil). The D. alata barks were dried at 37°
C over 48 hours and then powdered, ground in a mill,
macerated (200 g, during 5 days) in 2 L of 70% ethanol
and the suspension was then percolated (under protec-
tion against light) at 20 drops/min, resulting in a 20%
(m/v) hydroalcoholic extract [10]. After, the obtained
extract was concentrated under reduced pressure and
lyophilized providing 170 g (85% efficiency). It was
stored at room temperature without light and humidity
until the in vitro and in vivo toxicological assays were
performed.
Quality control assays of the vegetal drugs
Ash and humidity tests
In order to observe their elementary physical and che-
mical characteristics, D. alata powders were submitted
to ash and humidity tests [11]. Briefly, 100 g of powder
were placed in six calibrated melting pots, which were
warmed until total carbonization of the powders was
achieved. The melting pots were kept at 650°C and the
ashes were then weighed. Results are presented in grams
of ashes/100 g of sample. The humidity test was per-
formed by placing 1 g of specimen powder in six cali-
brated porcelain capsules, which were warmed at 105°C
for 4 h and then weighed.
Flavonoid content
The content of flavonoids was determined in the hydro-
alcoholic extract as described elsewhere [12]. The
method is based on the UV absorption of Al-Cl3-flavo-
noid complexes and is expressed as total content of
quercetin. Briefly, 80% methanol (50 mL) was added to
10 mL of extract and 5 mL of solution were transferred
to volumetric flasks and diluted again with 80% metha-
nol (50 mL). Four aliquots (2 mL) of solution were
mixed with 2 mL of 5% anhydrous aluminum chloride
solution (AlCl3; complexing agent) and adjusted to 10
mL with 80% methanol. After 15 min, the absorbance of
each sample was read at 420 nm, considering a blank
sample containing 80% methanol (8 mL) and 5% AlCl3
(2 mL). The percentage of flavonoids (%) was calculated
from a standard curve of quercetin (0, 4, 8, 12, and 16
μg/mL) prepared in methanol.
Polyphenol content
The content of polyphenols in the hydroalcoholic
extract of plant was determined as previously described
[13]. Five millilitres of extract was poured in a volu-
metric flask and distilled water was added to 250 mL,
after which a 1 mL aliquot was transferred to another
volumetric flask and distilled water added to 25 mL
(final solution). Aliquots (1 mL) of the final solution
received 1 mL of phosphomolybdotungstic reagent and
the final volume (10 mL) was adjusted with 15% sodium
carbonate solution. After 30 min, the absorbance of
sample was read at 720 nm, considering a blank sample
containing 15% sodium carbonate solution. The percen-
tage of polyphenols (%) was determined from a standard
curve (5, 10, 15, 20, 25, 30, 35, and 40 μg/mL) of pyro-
gallol (Sigma Chemical Co., St. Louis, MO, USA).
Biological tests
In vitro mutagenicity assay
The Salmonella mutagenicity assay was performed using
the pre-incubation method for 20 min [14] with S.
typhimurium strains TA100, TA98, TA97a and TA102
kindly provided by Dr. B. Ames, University of California,
Berkeley, CA, USA., with and without metabolic activa-
tion. The metabolic activation mixture (S9) was freshly
prepared before each test using an Aroclor-1254-
induced rat-liver fraction purchased (lyophilized) from
Moltox (NC, USA). S9 mix contained 4% (by volume)
S9 fraction. The D. alata extract was dissolved in
dimethyl sulfoxide (DMSO, Sigma Chemical Co., St.
Louis, MO, USA) in order to obtain the non toxic con-
centrations (3.6, 7.1, 14.1, and 21.2 mg/plate) for the S.
typhimurium strains obtained in a preliminary assay
(4.7, 9.4, 18.8, 28.2, and 37.6 mg/plate). Toxicity was
apparent either as a reduction in the number of His +
revertants, or as an alteration in the auxotrophic back-
ground (i.e. background lawn).
Each concentration of D. alata extract was added to 500
μL of 0.2 M sodium phosphate buffer (pH 7.4) and 100 μL
of each bacterial culture. After 20 min of incubation at 37°
C, 2 mL of molten top agar (0.6% agar, histidine and biotin
0.5 mM each, and 0.5% NaCl) was added and the mixture
was poured on to a plate containing minimal glucose agar
(1.5% Bacto-Difco agar and 2% glucose in Vogel-Bonner
medium E). The plates were incubated at 37°C for 48 h
and the His(+) revertant colonies were manually counted.
The influence of metabolic activation was tested by adding
500 μL of 4% S9 mix to the pre-incubation mixture. All
experiments were performed in triplicate. The standard
mutagens used as positive controls in the experiments
without S9 mix were sodium azide for TA100 (1.25 μg/
plate), 4-nitro-o-phenylenediamine (10 μg/plate) for TA98
and TA97a and mitomycin for TA102 (0.5 μg/plate). In
the tests with metabolic activation, 2-anthramine (1.25 μg/
plate) was used for all strains. DMSO was considered as
the negative control. Statistical analyses were performed
with the SALANAL statistical package software, using the
Bernstein et al. [15] model. The mutagenic index (MI),
defined as the average number of revertants per plate
divided by the average number of revertants per plate in
the negative control, was calculated for each dose. A sam-
ple was considered positive when the mutagenic index was
equal to or greater than two for at least one of the tested
concentrations, and if it had a reproducible dose-response
curve [16].
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In vitro LD50 of barks D. alata hydroalcoholic extract
The value of the LD50 (Lethal Dose to kill 50% of ani-
mals) essential for the controlled use of animals in tests
in vivo, was determined from the barks of D. alata
hydroalcoholic extract where inhibitory concentration
50%, the concentration required for 50% inhibition
(IC50 = 0.164 μg mL-1), using the formula: log (LD50
[mg mL-1]) = 0.372 × log IC50 (μg mL-1) + 2.024 [17].
Thus, the value of the LD50 for extract was 705 mg/kg
[9], which justifies the use of 0.5 g/kg, chosen for in
vivo experimental.
In vivo Experimental
Preparation of the aqueous D. alata extract Using the
lyophilized D. alata extract (see Plant material and
extraction), an aqueous extract was freshly prepared in
distillated/deionizated water before oral administration.
Animals
Male and female adult Wistar rats weighing 160 g to
200 g were supplied by Anilab - Animais de Laboratório
(Paulínia, São Paulo, Brazil). All animals were main-
tained in groups (5 rats per cage), previously housed to
laboratory conditions during one week before the
experiments at 25 ± 3°C on a 12-h light/dark cycle, and
had access to food and water ad libitum during all the
experimental days. This project (protocol number A079/
CEP/2007) was approved by the institutional Committee
for Ethics in Research of Vale do Paraiba University
(UNIVAP), and the experiments were carried out
according to the guidelines of the Brazilian College for
Animal Experimentation.
Reproductive ability evaluation
This reproductive evaluation method was previously
described by Gerenutti et al. [18,19]. Briefly, 26 sexually
naive rat females were mated with males (five females
with two males per cage). Pregnancy was confirmed
through the presence of spermatozoids in vaginal-wash-
ing rubbing observed by microscopy analysis [20]. The
presence of spermatozoids was considered as the first
day of pregnancy. Pregnant females were kept in sepa-
rate cages. Water and food were supplied ad libitum
during all the experiment and the consumption of both
was monitored daily. For reproductive evaluation each
group of 7 females received by gavage 0.5 g/kg/day of D.
alata extract (group 1) and 0.5 mL/kg/day of deionized
water (group 2) from days 0 to 22 of pregnancy.
The weight gain of pregnant females was followed up
during the pregnancy. For the teratogenic study each
group of 6 females received by gavage 0.5 g/kg/day of D.
alata extract (group 1) and 0.5 mL/kg/day of deionized
water (group 2) from days 0 to 21 of pregnancy.
Mothers were anesthetized with the inhalatory
halothane (Halotano®, Cristalia, Brazil), killed and sub-
mitted to a rapidly excision of their uterus. The
following macroscopics parameters were evaluated in
order to observe the reproductive performance of rats
[18,21]:
1) placenta weight (grams)
2) fetus weight (grams)
3) pre-implantation loss (%) = corpora lutea number -
implantation number corpora lutea number
4) post-implantation loss (%) = implantation number -
alive fetus number implantation number
5) offspring vitality (%)
The offspring was anesthetized, killed and fixed in
Bouin’s solution for 24-48 h, replacing it by a 70%
hydroalcoholic solution in order to measure the follow-
ing parameters (in cm): antero-posterior and latero-lat-
eral of cranio; antero-posterior and latero-lateral of
thorax; cranio-caudal and tail. Other offspring group
was anesthetized, killed, eviscerated and diaphanizated
for posterior skeletal examination. Fetuses selected are
fixed in ethanol, then “cleared” and stained by a KOH-
alizarin red-S technique [22]. Examination includes enu-
meration of the vertebra, ribs, and other bone struc-
tures, degree of ossification, and any fusions or
abnormalities in bone shape or position [23]. Figure 1
illustrates fetuses fixed in Bouin’s solution or post-
diaphanizated.
Evaluation of the physical development of rat offspring
The parturition day was defined as first day of life of the
litter. On this first day, the offspring was examined
externally (macroscopically) and sexed. The same male
and female pups were used for the physical and develop-
mental tests. Pups that have been exposed prenatally
either to D. alata extract or to placebo were submitted
to the physical parameters and the behavioral tasks at
the same time during the infancy. The following physi-
cal development parameters [24] were observed during
21 days: offspring weight; fluff and hair appearing; inci-
sor teeth eruption; ear unsticking/ear opening; eyes
opening; testis descent; vagina opening.
Neurobehavioral development assays
Two validated methods were adopted for evaluating the
neurobehavioral development [19] of pups: latency for
uprightness and open field assay (ambulation, rearing
frequency, cleaning activity and immobility time). These
parameters were measured at 13th day and ended at
21st day.
Statistical analysis
Data from the different assays were first analyzed
regarding distribution and variance homogeneity. Nor-
mally distributed data were submitted to comparison
between both groups by using Student’s t-test. Non-nor-
mally distributed data were first transformed (log). The
Student’s t-test was also used when the transformation
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changed the distribution to normal or the Mann-Whit-
ney (Wilcoxon rank sum test) was used if the distribu-
tion was still non-normal. The Litchfield and Wilcoxon
test [25] were used for evaluation of physical develop-
ment parameters. The significance level was set at 5%.
Results and discussion
There is a general belief that herbal remedies are safe
because they are natural [26]. Here, it was revealed data
such as ashes and humidity - important to attribute a
quality control of a given plant. Each 100 g of D. alata
powder contain 1.55 ± 1.1 g of ashes and 9.5 ± 0.1 g of
humidity. It was also expressed the flavonoids and poly-
phenols content of D. alata barks as being 0.42% flavo-
noids and 3.66% polyphenols, quantified using quercetin
calibration curve (Y = 0.0632X + 0.0035, R = 0.998) and
pyrogallol calibration curve (Y = 0.1693X - 0.0004, R =
0.999), respectively. Recently, some chemical constitu-
ents of D. alata were identified [27] such as triterpe-
noids, isoflavonoids and phenolic acids. These two latter
constituents belong to the phenolic compounds, term
that embraces a wide range of plant substances, a lot of
them of the great biological importance [12].
This is the first time that mutagenicity of D. alata
extract was investigated using Salmonella (Ames test)
assay, which has 58% sensitivity to rodent carcinogens,
and 73% specificity for noncarcinogens [28]. The S.
typhimurium used in this assay has a defect in one of
genes involved in histidine biosynthesis that renders the
cell dependent (auxotrophic) on exogenous histidine.
Unless the cell experiences a mutation that revert the
dysfunctional gene back to the wild type (prototrophic),
the cell becomes disabled when the exogenous histidine
is exhausted. For this reason, this assay is referred to as
a “reverse” or “back” mutation assay [29], since muta-
tional events can be predictable [30].
Table 1 shows the revertants frequency, the standard
deviation and the mutagenicity index (MI) after the
treatments with hydroalcoholic extract of D. alata bark,
in the four different strains of Salmonella typhimurium,
with or without metabolic activation. The extract was
non-mutagenic to any of the assessed strains TA97a,
TA98, TA100 and TA102 even after metabolic activa-
tion. All values of MI were lower than 2 indicating the
absence of any mutagenic activity.
Previously, the extract was cytotoxic for TA97a (-S9,
+S9), TA100 (+S9) and TA102 (-S9, +S9) at the highest
assessed concentrations (28.2 and 37.6 mg/plate). Thus,
lower concentrations were used showing the ideal con-
ditions for carrying out a mutagenic assay. These results
show a high confidence of D. alata as a non-mutagen
[28] even under metabolic activation.
Additional evidences of D. alata safety were provided
from in vivo assays, since the D. alata-tea consumption
is a very common habit, mainly during the pregnancy.
Here, a set of several parameter was performed, such as
Figure 1 Gestation evaluation (21st day) under Bouin’s fluid-fixed or diaphanizated fetuses. CL, clavicule. CR, cranio. PE, pelvis. VS,
vertebral spine.
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the reproductive ability evaluation; weight gain of preg-
nant females (Figure 2); reproductive performance of
pregnant rats (Tables 2 and 3); and offspring survival
effects - pups physical development (Figure 3, Table 4);
and pups neurobehavioral development (Figures 4 and 5).
Figure 2 shows the mean (± SD) weight gain during
the gestation considering water ingestion and food con-
sumption ad libitum. At the 0.05 level (t-test), the two
means (control compared to D. alata extract) are not
significantly different.
Table 2 shows the reproductive performance of preg-
nant rats exposed to D. alata extract (n = 7) and com-
pared to control group (n = 7). Five parameters were
taken into account: 1) placenta weight, 2) pups weight,
3) pre-implantation loss, 4) post-implantation loss; and
5) offspring vitality. The results show that even adminis-
trating daily a concentration of 0.5 g/kg no effects were
observed on the offsprings (t-test, p > 0.05).
Table 3 shows the results obtained after the measure-
ment of offspring external morphological parameters
Table 1 Mutagenic activity (mean of the number of revertants/plate ± SD) of the bacterial strains TA98, TA100, TA97a
and TA102 exposed to Dipteryx alata Vogel hydroalcoholic extract, at various concentrations, with (+S9) or without
(-S9) metabolic activation
Treatment
(mg/plate)
TA98 TA100 TA97a TA102
- S9 + S9 - S9 + S9 - S9 + S9 - S9 + S9
0* 25 ± 1.0 23 ± 2.5 155 ± 5.9 207 ± 19.0 197 ± 3.5 188 ± 121 275 ± 14.5 200 ± 9.0
3.6 - - - 201 ± 23.5 (0.9) 227 ± 10.8* (1.2) 213 ± 9.9 (1.1) 229 ± 31.8 (0.9) 277 ± 26.9 (1.4)
4.7 25 ± 1.0 (1.0) 23 ± 2.9 (1.0) 135 ± 4.0 (0.9) - - - - -
7.1 - - - 238 ± 16.5 (1.1) 203 ± 13.5 (1.0) 199 ± 3.5 (1.1) 218 ± 12.1 (0.9) 299 ± 4.6* (1.5)
9.4 40 ± 8.7* (1.6) 24 ± 2.7 (1.0) 149 ± 10.0 (0.9) - - - - -
14.1 - - - 220 ± 14.8 (1.1) 201 ± 18.9(1.0) 198 ± 12.0 (1.1) 223 ± 3.5 (0.9) 303 ± 5.5* (1.5)
18.8 31 ± 4.4 (1.2) 23 ± 2.0 (1.0) 193 ± 11.7 (1.3) - - - - -
21.2 - - - 190 ± 16.9 (0.9) 158 ± 31.2 (0.8) 188 ± 7.4 (1.0) 204 ± 15.0 (0.7) 291 ± 1.5 (1.4)
28.2 38 ± 2.9* (1.5) 23 ± 2.1 (1.0) 208 ± 14.0 (1.3) - - - - -
37.6 32 ± 6.7 (1.3) 23 ± 2.1 (1.0) 226 ± 40.0* (1.5) - - - - -
Control + 2757 ± 208.5d 879 ± 46.1a 923 ± 134.6b 1357 ± 10.6 a 1470 ± 85.9 d 1210 ± 14.5 a 1733 ± 149.7 c 1280 ± 15.3 a
-: not assayed; 0*: negative control (DMSO, 100 μL/plate); Control +: positive control; a 2-Anthramine (1.25 μg/plate); b Sodium azide (1.25 μg/plate); c Mitomycin
(0.5 μg/plate); d4-nitro-o-phenylenediamine (10.0 μg/plate); * p < 0.05 (ANOVA). The values in brackets represent the mutagenic index.
Figure 2 Effects (mean ± SD) of the D. alata aqueous extract on the weight gain of pregnant rats. There were no statistically significant
differences (p > 0.05, t-test) between the D. alata and control groups.
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using Bouin’s fluid-fixed specimens. No incidence of
malformations was seen in this study. There were no
statistically significant differences between the animals
treated with D. alata (0.5 g/kg) or control groups (p >
0.05, t-test) during pre-birth period.
No effect on bone tissue was observed during pre-
birth period in the offspring exposed to 0.5 g/kg D.
alata and diaphanizated when compared to the control
group (data not shown). The skeletal development (Fig-
ure 1), with ossification of clavicule (CL), cranio (CR),
pelvis (PE) and vertebral spine (VS) and other structures
were normal in both groups with no statistically signifi-
cant difference between them.
It is well known that when retardation in the uterus
growth occurs, a delay or reduction in skeletal ossifica-
tion and, in some cases, increases in minor skeletal var-
iations is often present. This is observed with test agents
that exert their effects through maternal toxicity [23].
Agents known to interfere directly with fetal nutrition,
growth factors, and other developmental processes may
also induce growth retardation by a direct effect on the
fetus [31]. Under some circumstances, the induction of
skeletal variations such as supernumerary and wavy ribs
is considered the result of maternal toxicity or stress
rather than a direct toxic effect on the conceptus [32].
The evaluation of pups’ physical development accord-
ing to offspring weight is shown in Figure 3. Data are
presented as mean ± SD weight gain of pups (female
and male) previously exposed to aqueous D. alata
extract during the pregnancy.
After birth, growth can be affected by alterations in
maternal care, milk production, or milk ejection reflexes,
or even by direct effects on pup’s suckling behavior or
continued test material exposure through milk [23]. In
this study, there were no statistically significant
Table 2 Reproductive performance of pregnant rats
exposed to D.alata Vogel
Parameters Treatments
Control
(n = 7)
D. alata Vogel
(0.5 g/kg) (n = 7)
Placenta weight (in grams) 0.53 ± 0.12 0.49 ± 0.11
Fetus weight (in grams) 2.24 ± 0.55 2.05 ± 0.51
Pre-implantation loss (%) 3.57 4.59
Post-implantation loss (%) 4.9 9.9
Offspring vitality (%) 100 100
Table 3 Effects of D.alata extract administered during rat
pregnancy on the offsprings
Treatment
Fetus measurement
(in cm)
Control
(mean ± SD)
(n = 39)
D. alata extract (0.5 g/kg)
(mean ± SD)
(n = 41)
Antero-posterior of cranio 11. 74 ± 2. 19 13.69 ± 1.10
Latero-lateral of cranio 7.00 ± 2. 27 8.28 ± 0.72
Antero-posterior of thorax 8.23 ± 1.96 9.28 ± 1. 13
Latero-lateral of thorax 7.94 ± 2. 16 9.89 ± 1.23
Cranio-caudal 26.24 ± 3.07 26.51 ± 3.00
Tail 9.69 ± 1.70 10.56 ± 1.71
Figure 3 Weight gain of female (15 animals per group) and male (15 animals per group) pups exposed to D. alata extract or
deionized water (control) during pregnancy. There were no statistically significant differences between the groups (p > 0.05, t-test).
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differences between both groups (control and treated),
nor between the genders (female and male).
Table 4 shows the result of physical development
according to the effective time (in days) necessary to
verify the initialization of each parameter. There were
no statistically significant difference (p > 0.05, Litchfield
test) between male and female animals when compared
to their respective controls.
These results taken together show a safety profile of
D. alata consumption during rat’s pregnancy. Absorp-
tion by fetus depends on the maternal dose, which in
turn depends on the physical and chemical properties of
the extract. Toxicity can be direct organ-related toxicity,
as hepatocellular necrosis [33]; or indirect, as hyperes-
trogenism, resulted from excessive consumption of phy-
toestrogens found in many plants [34]. None adverse
effect was observed in the rats as well as in theirs off-
springs when 0.5 g/kg D. alata extract was administered
to the pregnant rats.
The herbal medicine governmental regulation has
been addressed mainly to chemicals and drugs that
affect the nervous system and behavior, particularly nar-
cotic plants due to the addictive risk and other social
issues [26]. The definition of neurotoxicity, however, is
“any adverse effect on the structure or function of the
nervous system related to exposure to a chemical sub-
stance” [35]. In this context, the offspring neurobeha-
vioral development was also evaluated for D. alata.
Latency for uprightness (Figure 4) and open-field (Fig-
ure 5) tests were performed for assessing the neurobeha-
vioral and functional integrity of nervous system.
Figure 4 shows the latency for uprightness for both
female and male pups. There were no statistically signif-
icant difference (p > 0.05, t-test) considering both
genders.
Figure 5 shows the results on the general physical
activity including ambulation, rearing frequency, clean-
ing activity and immobility time of female and male
pups during the open field assay.
Table 4 Mean time (in days) necessary to develop of
each physical parameter considering male and female
pups exposed to aqueous D.alata extract or deionized
water (control) during pregnancy
Parameters Male Female
Control
(n =
15)
D.alata
extract
(n = 15)
Control
(n =
15)
D.alata
extract
(n = 15)
Fluff appearing 1-2 1-2 1-3 1-2
Hair appearing 4-5 4-5 3-5 4-5
Incisor teeth eruption 8-11 9-11 8-11 9-10
Ear unsticking/ears
opening
12-14 13-15 12-14 13-16
Eyes opening 13-16 13-15 14-16 14-17
Testis descent 20-22 20-24 - -
Vagina opening - - 38-39 34-42
Figure 4 Latency for uprightness (mean ± SD) of female and male pups exposed to D. alata extract and deionized water (control)
during the pregnancy. (p > 0.05, t-test).
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Both female and male pups exposed to D. alata showed
a sporadic reduction on the ambulation parameter, show-
ing statistically significant differences at 19th and 21st
days, respectively, when compared to their controls. The
number of times the animal rears (defined as any time
both front paws leave contact with the floor) showed no
statistically differences among groups.
Female offspring exposed to D. alata showed a reduc-
tion in the cleaning behavioral at 20th day. The immobi-
lity time of these animals showed an increase at 17th
and 19th days. The results showed in Figure 5 may arise
some functional effect in the offspring of mothers
exposed to the D. alata during pregnancy. However,
these effects were sporadic.
Conclusion
In conclusion, the analysis of all results indicated that
the administration of 0.5 g/kg D. alata extract during
pregnancy in rats is safe, causing no abnormalities and
when evaluated by Salmonella microsome assay the
extract was not mutagenic.
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